[Study of the pharmacological properties of 3-dimethylsulfonamido 10-(2-dimethylamino-propyl) phenothiazine (8.599 RP)].
D000707:Anaphylaxis / Q000517:prevention & control; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D051379:Mice; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D010437:Peptic Ulcer / Q000517:prevention & control; D010640:Phenothiazines / Q000494:pharmacology* / Q000633:toxicity; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000187:drug effects
D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010640:Phenothiazines; D012701:Serotonin; D011398:Promethazine
Etude des propriétés pharmacologiques de la diméthylsulfamido-3 (diméthylamino-2-propyl)-10 phénothiazine (8.599 R.P.)